Skip to main content
. 2012 Jan 6;72(11):1495–1520. doi: 10.2165/11635490-000000000-00000

Fig. 3.

Fig. 3

Pharmacokinetics and pharmacodynamics of biphasic insulin aspart 30 and biphasic human insulin 30. (a) Serum insulin concentration (reproduced from Jacobsen et al.,[17] with kind permission from Springer Science+Business Media). (b) Insulin action (reproduced from Weyer et al.,[16] with permission from the American Diabetes Association. © 1997 American Diabetes Association). BHI = biphasic human insulin; BIAsp = biphasic insulin aspart; * p < 0.0001.